Predict your next investment

HEALTHCARE | Biotechnology
swiftbiosci.com

See what CB Insights has to offer

Total Raised

$35.13M

Investors Count

9

Deal Terms

3

Swift Biosciences Funding, Swift Biosciences Valuation & Swift Biosciences Revenue

10 Fundings

Swift Biosciences's latest funding round was a Acquired for on March 11, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/11/2021

Acquired

$0.00B

((9.99x))

FY 1234

5

4/15/2020

Loan

$0.68M

$0.00B

((9.99x))

FY 1234

11/13/2018

Series E

$4M

$0.00B

((9.99x))

FY 1234

1

6/12/2017

Series D

$99M

$0.00B

((9.99x))

FY 1234

10

1/27/2017

Debt

$99M

$0.00B

((9.99x))

FY 1234

10

Date

3/11/2021

4/15/2020

11/13/2018

6/12/2017

1/27/2017

Round

Acquired

Loan

Series E

Series D

Debt

Amount

$0.68M

$4M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

5

1

10

10

Swift Biosciences Deal Terms

3 Deal Terms

Swift Biosciences's deal structure is available for 3 funding rounds, including their Series B from October 16, 2013.

Round

Series B

Series A - II

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

$99M

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A - II

$99M

$99M

$99M

$99M

Series A

Swift Biosciences Investors

9 Investors

Swift Biosciences has 9 investors. Integrated DNA Technologies invested in Swift Biosciences's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/11/2021

3/11/2021

1
Acquired

Corporation

Iowa

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Texas

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporate Venture

Massachusetts

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Michigan

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Connecticut

First funding

3/11/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

3/11/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Corporation

Venture Capital

Corporate Venture

Venture Capital

Venture Capital

Location

Iowa

Texas

Massachusetts

Michigan

Connecticut

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.